Status:
COMPLETED
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Opioid-Related Disorders
Substance-Related Disorders
Eligibility:
All Genders
19-57 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
End Date :
October 1 1997
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000353
Start Date
October 1 1996
End Date
October 1 1997
Last Update
January 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178